A Deadly Disease

White, Tekla N.
January 1996
Missions of San Francisco Bay Area;1996, p47
Smallpox, a skin disease, had killed millions of people in Europe, Asia, and Africa before reaching the Indians of California. For centuries, no one knew how to cure the deadly disease. Some neophytes at the missions eventually received treatment. But Native Americans living outside the missions had no resistance to the disease. During mission times, a British scientist developed the first vaccine to fight smallpox. But no treatment was foolproof, and some people who took the vaccine still became ill.


Related Articles

  • Smallpox Vaccination.  // Annals of Internal Medicine;Feb67, Vol. 66 Issue 2, p358 

    Reprints the article on smallpox vaccination, published in the November 26, 1966 issue of the 'Morbidity and Mortality Weekly Report.'

  • LETTER from LONDON. Dixon, Bernard // Sciences;May/Jun77, Vol. 17 Issue 3, p28 

    Presents a letter on the application of vaccine for smallpox management in London, England. Role of penicillin in the administration of the disease; Difference between vaccination and variolation; Epidemiology of human smallpox.

  • Smallpox: We'll Soon Have Enough Vaccine...  // Child Health Alert;May2002, Vol. 20, p1 

    Focuses on smallpox vaccine in the U.S.

  • Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options. Lane, J. Michael // Annals of Internal Medicine;3/18/2003, Vol. 138 Issue 6, p488 

    Presents a review of the clinical presentations of major adverse events after smallpox vaccination and the rates of occurrence of these events observed in the 1960s in the United States. Renewed interest in a smallpox vaccination program following reports of a possible terrorist attack using...

  • Smallpox Vaccine Adverse Events Among Civilians--United States, February 18-24, 2003.  // MMWR: Morbidity & Mortality Weekly Report;2/28/2003, Vol. 52 Issue 8, p156 

    Summarizes smallpox vaccine-associated adverse events reported among civilians vaccinated in the U.S. as of February 21, 2003. Classification of the adverse events; Provision of the smallpox vaccine to civilian health-care and public health workers; Signs and symptoms of adverse events.

  • Preventing a Pox Americana. Skloot, Rebecca; Hirshberg, Charles // Popular Science;Dec2002, Vol. 261 Issue 6, p21 

    Discusses the issues on the importance of smallpox vaccine on people in the U.S. facing threats of bioterrorism. Risks of smallpox vaccine; Sources of smallpox vaccine; Opposition on childhood immunizations of smallpox.

  • Inappropriate Use of Smallpox Vaccine.  // Clinical Pediatrics;Jan1983, Vol. 22 Issue 1, p10 

    Discusses concerns of the medical community on the adverse reactions to smallpox vaccination used to treat herpes infections in the U.S. Recommendations for the application of smallpox vaccines; Details on the therapeutic value of smallpox vaccination; Relation of smallpox to orthopox viruses.

  • Liability concerns hinder vaccinations.  // AHA News;2/24/2003, Vol. 39 Issue 4, p8 

    Claims that liability and compensation concerns may hinder the government efforts toward smallpox vaccination in the U.S. in 2003.

  • The Big Deal about Smallpox. Jacobs, Liz // Revolution: The Journal for RNs & Patient Advocacy;Jan/Feb2003, Vol. 4 Issue 1, p22 

    Explores why the medical community is against the smallpox vaccination program of the U.S. government. Transmission risks; Volatility of the vaccinia virus in the vaccination; Safety of the vaccines.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics